Medicine and science in the fight against doping in sport

Journal of Internal Medicine

Volumn 264, Issue 2, 2008, Pages 99-114

  Catlin, D H ^a,b   Fitch, K D ^c   Ljungqvist, A ^d  

^a Anti Doping Research Inc   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Doping; Doping in sports; Mass spectrometry; Olympic games; Sports; Substance abuse detection

Indexed keywords

ANABOLIC AGENT; HUMAN GROWTH HORMONE; METANDIENONE; NORBOLETONE; RECOMBINANT ERYTHROPOIETIN; TESTOSTERONE; TETRAHYDROGESTRINONE;

BLOOD EXAMINATION; BLOOD TRANSFUSION; DIET SUPPLEMENTATION; DOPING; DRUG MISUSE; FLOW CYTOMETRY; GAS CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PRIORITY JOURNAL; REVIEW; URINALYSIS;

ANABOLIC AGENTS; BLOOD CHEMICAL ANALYSIS; DOPING IN SPORTS; DRUG THERAPY; ERYTHROPOIETIN, RECOMBINANT; ETHICS, MEDICAL; FEMALE; FLOW CYTOMETRY; HUMAN GROWTH HORMONE; HUMANS; INTERNATIONAL AGENCIES; INTERNATIONAL COOPERATION; MALE; MASS SPECTROMETRY; SPORTS; SUBSTANCE ABUSE DETECTION;

EID: 46949095888     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2008.01993.x     Document Type: Review

References (50)

1. Dirix A, Sturbois X. The First Thirty Years of the International Olympic Committee Medical Commission. Lausanne : The International Olympic Committee, 1998.
2. Beckett AH, Cowan DA. Misuse of drugs in sport. Br J Sports Med 1979 12 : 185 94.
3. Dirix A. Medical Guide of the IOC Medical Commission. Lausanne : International Olympic Committee 1992 53 90.
4. World Anti-Doping Agency. http://www.wada-ama.org/
5. Klein HG. Blood transfusion and athletes. N Engl J Med 1985 312 : 854 6.
6. ISO. International Standards for Business Government and Society ISO, 2008.
7. Berendonk B. Doping Dokumente. Berlin : Springer-Verlag, 1991.
8. Franke WW, Berendonk B. Hormonal doping and androgenization of athletes: a secret program of the German Democratic Republic government. Clin Chem 1997 43 : 1262 79.
9. Yesalis CE, Courson SP, Wright J. History of anabolic steroid use. In : Yesalis CE, ed. Anbolic Steroids in Sport and Exercise. Champaign, IL : Human Kinetics, 1993 36 40.
10. Ljungqvist A. The use of anabolic steroids in top Swedish athletes. Br J Sports Med 1975 9 : 82.
11. World Anti-Doping Agency. WADA code. Montreal : WADA. http://www.wada-ama.org, accessed 12 January 2008.
12. Thiblin I, Parlklo T. Anabolic androgenic steroids and violence. Acta Psychiatr Scand Suppl 2002 412 : 125 8.
13. Pope HG Jr., Katz DL. Homicide and near-homicide by anabolic steroid users. J Clin Psychiatry 1990 51 : 28 31.
14. Pope HG Jr., Katz DL. Psychiatric and medical effects of anabolic-androgenic steroid use. A controlled study of 160 athletes. Arch Gen Psychiatry 1994 51 : 375 82.
15. Sullivan ML, Martinez CM, Gennis P, Gallhager EJ. The cardiac toxicity of anabolic steroids. Prog Cardiovasc Dis 1998 41 : 1 15.
16. Bagheri SA, Boyer JL. Peliosis hepatis associated with androgenic-anabolic steroid therapy. A severe form of hepatic injury. Ann Intern Med 1974 81 : 610 8.
17. Baoutina A, Alexander IE, Rasko JE, Emslie KR. Developing strategies for detection of gene doping. J Gene Med 2008 10 : 3 20.
18. Schneider AJ, Friedmann T. Gene doping in sports: the science and ethics of genetically modified athletes. Adv Genet 2006 51 : 1 110.
19. Donike M, Jaenicke L, Stratmann D, Hollmann W. Gaschromatographischer Nachweis von stickstoffhaltigen Pharmaka in wassrigen Losungen mit dem Stickstoffdetektor. J Chromatography 1970 52 : 237 50.
20. Dugal R, Dupuis C, Bertrand MJ. Radioimmunoassay of anabolic steroids: an evaluation of three antisera for the detection of anabolic steroids in biological fluids. Br J Sports Med 1977 11 : 162 9.
21. Donike M, Barwald KR, Klostermann K, Schanzer W, Zimmerman J. Nachweis von exogenem Testosteron (The detection of exogenous testosterone). In : Heck H, Holmann W, Liesen H, Rost R, eds. Sport: Leistung und Gesundheit. Koln : Deutscher Arzte-Verlag, 1983 293 8.
22. Catlin DH, Hatton CK, Starcevic SH. Issues in detecting abuse of xenobiotic anabolic steroids and testosterone by analysis of athletes' urine. Clin Chem 1997 43 : 1280 8.
23. Catlin DH, Kammerer RC, Hatton CK, Sekera MH, Merdink JL. Analytical chemistry at the Games of the XXIII Olympiad in Los Angeles, 1984. Clin Chem 1987 33 : 319 27.
24. Schulze JJ, Lundmark J, Garle M, Skilving I, Ekström L, Rane A. Doping test results dependent on genotype of UGT2B17, the major enzyme for testosterone glucuronidation. J Clin Endocrinol Metab 2008 Mar 11. [Epub ahead of print] PMID 18334693.
25. Aguilera R, Chapman TE, Catlin DH. Performance characteristics of a carbon isotope ratio method for detecting doping with testosterone based on urine diols: controls and athletes with elevated testosterone/epitestosterone ratios. Clin Chem 2001 47 : 292 300.
26. World Anti-Doping Agency. TD2004EAAS, WADA Technical Document on Reporting and Evaluation Guidance for Testosterone, Epitestosterone, T/E Ratio and Other Endogenous Steroids. Montreal : WADA, 2008. http://www.wada-ama.org, accessed 1 June 2008.
27. Schanzer W, Geyer H, Fussholler G et al. Mass spectrometric identification and characterization of a new long-term metabolite of metandienone in human urine. Rapid Commun Mass Spectrom 2006 20 : 2252 8.
28. Catlin DH, Hatton CK, Lasne F. Abuse of recombinant erthropoietins by athletes. In : Molineux G, Foote MA, Elliott SG, eds. Erythropoietins and Erythropoiesis. Basel, Boston, Berlin : Birkhauser Verlag, 2006 205 27.
29. Union Cycliste Internationale. Cycling Regulations Part 13. Sporting Safety and Conditions, Aigle:UCI pp. 8, paragraph 13. 1. 063.
30. Parisotto R, Wu M, Ashenden MJ et al. Detection of recombinant human erythropoietin abuse in athletes utilizing markers of altered erythropoiesis. Haematologica 2001 86 : 128 37.
31. Wide L, Bengtsson C, Berglund B, Ekblom B. Detection in blood and urine of recombinant erythropoietin administered to healthy men. Med Sci Sports Exerc 1995 27 : 1569 76.
32. Lasne F, de Ceaurriz J. Recombinant erythropoietin in urine. Nature 2000 405 : 635.
33. Lasne F. Double-blotting: a solution to the problem of non-specific binding of secondary antibodies in immunoblotting procedures. J Immunol Methods 2001 253 : 125 31.
34. Catlin DH, Breidbach A, Elliott S, Glaspy J. Comparison of the isoelectric focusing patterns of darbepoetin alfa, recombinant human erythropoietin, and endogenous erythropoietin from human urine. Clin Chem 2002 48 : 2057 9.
35. Nelson M, Popp H, Sharpe K, Ashenden M. Proof of homologous blood transfusion through quantification of blood group antigens. Haematologica 2003 88 : 1284 95.
36. American Arbitration Association. United States Anti-Doping Agency v Tyler Hamilton. 30-190-111130-05. New York : American Arbitration Association, 2005.
37. Powrie JK, Bassett EE, Rosen T et al. Detection of growth hormone abuse in sport. Growth Horm IGF Res 2007 17 : 220 6.
38. Wallace JD, Cuneo RC, Lundberg PA et al. Responses of markers of bone and collagen turnover to exercise, growth hormone (GH) administration, and GH withdrawal in trained adult males. J Clin Endocrinol Metab 2000 85 : 124 33.
39. Wu Z, Bidlingmaier M, Dall R, Strasburger CJ. Detection of doping with human growth hormone. Lancet 1999 353 : 895.
40. Alexander B. The awful truth. Outside July 2005 100 8.
41. Geyer H, Parr MK, Mareck U, Reinhart U, Schrader Y, Schanzer W. Analysis of non-hormonal nutritional supplements for anabolic-androgenic steroids - results of an international study. Int J Sports Med 2004 25 : 124 9.
42. Leder BZ, Longcope C, Catlin DH, Ahrens B, Schoenfeld DA, Finkelstein JS. Oral androstenedione administration and serum testosterone concentrations in young men. JAMA 2000 283 : 779 82.
43. Catlin DH, Leder BZ, Ahrens B et al. Trace contamination of over-the-counter androstenedione and positive urine test results for a nandrolone metabolite. JAMA 2000 284 : 2618 21.
44. Catlin DH, Ahrens BD, Kucherova Y. Detection of norbolethone, an anabolic steroid never marketed, in athletes' urine. Rapid Commun Mass Spectrom 2002 16 : 1273 5.
45. Catlin DH, Sekera MH, Ahrens BD, Starcevic B, Chang YC, Hatton CK. Tetrahydrogestrinone: discovery, synthesis, and detection in urine. Rapid Commun Mass Spectrom 2004 18 : 1245 9.
46. Breidbach A, Catlin DH. RSR13, a potential athletic performance enhancement agent: detection in urine by gas chromatography/mass spectrometry. Rapid Commun Mass Spectrom 2001 15 : 2379 82.
47. Thevis M, Opfermann G, Schanzer W. Detection of the plasma volume expander hydroxyethyl starch in human urine. J Chromatogr B Biomed Sci Appl 2000 744 : 345 50.
48. Thevis M, Ogorzalek Loo RR, Loo JA, Schanzer W. Doping control analysis of bovine hemoglobin-based oxygen therapeutics in human plasma by LC-electrospray ionization-MS/MS. Anal Chem 2003 75 : 3287 93.
49. World Anti-Doping Agency. International Standard for Therapeutic Use Exemptions. Montreal : WADA, 2007. Accessed 29 January 2008.
50. World Anti-Doping Agency. Medical Information to Support the Decisions of Therapuetic Use Exemption Committees. Montreal : WADA, 2007. http://www.wada-ama.org, accessed 26 January 2008.